BeStock  
Stocks › ARWR

Arrowhead Pharmaceuticals ARWR

US equityMarket cap rank #1888
$41.37 −$2.28 (-5.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $41.40 +0.07%
Open$43.15
Prev close$43.65
Day range$41.17 – $44.80
Volume3.91M
Market cap$5.85B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts11
Average target$106.63+157.7% vs. price
  • Buy 91%
  • Hold 9%
Low $74.00Now $41.37Avg $106.63High $126.00

Recent rating changes

The last 20 actions on file set price targets from $74.00 to $126.00, averaging $112.06.

DateFirmRatingTarget
13 Nov 2026 Piper Sandler BUY $126.00
13 Nov 2026 BofA Securities BUY –
13 Nov 2026 Morgan Stanley BUY $106.00
13 Nov 2026 Stifel BUY $96.00
13 Nov 2026 RBC Capital BUY $100.00
11 Nov 2026 H.C. Wainwright BUY $120.00
10 Nov 2026 Piper Sandler BUY $126.00
10 Nov 2026 B. Riley Securities BUY $123.00
5 Nov 2026 H.C. Wainwright BUY $120.00
15 Oct 2026 Piper Sandler BUY $126.00
15 Oct 2026 H.C. Wainwright BUY $120.00
15 Oct 2026 J.P. Morgan BUY –
14 Oct 2026 Citi BUY $108.00
14 Oct 2026 H.C. Wainwright BUY $120.00
12 Oct 2026 BofA Securities BUY $100.00
24 Sep 2026 Goldman Sachs HOLD $74.00
21 Sep 2026 H.C. Wainwright BUY $120.00
16 Sep 2026 Citi BUY –
15 Sep 2026 J.P. Morgan BUY –
9 Sep 2026 Citi BUY $108.00

Discussion

No comments yet — be the first to weigh in on ARWR.

Sign in to join the discussion.

Scroll to Top